Aperio Group, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$3,575,000
+78.7%
83,719
+10.0%
0.01%
+57.1%
Q3 2020$2,001,000
+15.3%
76,121
+17.6%
0.01%
+16.7%
Q2 2020$1,735,000
+80.4%
64,709
+21.0%
0.01%
+50.0%
Q1 2020$962,000
+18.5%
53,464
+16.8%
0.00%
+33.3%
Q4 2019$812,000
+40.2%
45,779
+22.6%
0.00%
+50.0%
Q3 2019$579,000
+25.9%
37,333
+39.5%
0.00%0.0%
Q2 2019$460,000
+11.4%
26,756
+4.4%
0.00%0.0%
Q1 2019$413,000
+20.4%
25,636
+9.2%
0.00%0.0%
Q4 2018$343,000
+12.5%
23,467
+39.9%
0.00%
+100.0%
Q3 2018$305,000
+15.5%
16,777
+7.2%
0.00%0.0%
Q2 2018$264,000
-24.1%
15,643
-12.0%
0.00%
-50.0%
Q1 2018$348,000
-0.9%
17,769
+2.4%
0.00%0.0%
Q4 2017$351,000
+29.5%
17,347
+11.1%
0.00%0.0%
Q3 2017$271,000
-26.8%
15,618
-45.8%
0.00%0.0%
Q2 2017$370,000
+96.8%
28,823
+99.2%
0.00%
+100.0%
Q1 2017$188,000
+34.3%
14,470
+2.5%
0.00%0.0%
Q4 2016$140,000
-36.4%
14,120
-22.3%
0.00%
-50.0%
Q3 2016$220,000
+107.5%
18,178
+48.4%
0.00%
+100.0%
Q2 2016$106,000
-25.4%
12,252
+16.0%
0.00%0.0%
Q3 2015$142,000
-33.6%
10,566
+11.7%
0.00%
-50.0%
Q2 2015$214,0009,4590.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Third Security, LLC 19,829,337$266,308,00010.60%
BB BIOTECH AG 6,929,832$93,068,0002.95%
SECTORAL ASSET MANAGEMENT INC 2,671,051$35,872,0001.64%
Sterling Global Strategies LLC 22,000$295,0001.63%
Lombard Odier Asset Management (USA) Corp 1,061,547$14,257,0001.24%
PYRRHO CAPITAL MANAGEMENT, LP 90,000$1,209,0001.04%
IRIDIAN ASSET MANAGEMENT LLC/CT 8,184,003$109,911,0000.93%
Bellevue Asset Management AG 246,000$3,304,0000.54%
Convergence Investment Partners, LLC 251,748$3,381,0000.39%
Rhenman & Partners Asset Management AB 172,000$2,310,0000.37%
View complete list of HALOZYME THERAPEUTICS INC shareholders